NYSE:GMED
Globus Medical (GMED)
Financials 
Technical Analysis 
Jul 2, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Globus Medical (GMED-N) is facing significant challenges in the current market environment, particularly within the medical devices sector. Recent sentiments indicate a general aversion towards medical device companies, compounded by a perception of limited profitability among larger competitors such as Medtronic. Investors might be wary of investing in GMED-N given these prevailing conditions, leading to skepticism about its future performance and market positioning. The industry's ongoing struggles could affect smaller players like Globus Medical, prompting a cautious approach from analysts and investors alike. As the market dynamics evolve, it remains essential for Globus Medical to demonstrate stability and growth to attract investor confidence amid these challenging circumstances.
He recommended it around 18 months ago, and it has doubled in price. Drawbacks before: had no international presence and not enough salespeople, but that has turned around, as reflected in the price jump. Earnings growing 10-15% annually. No debt, but pay no dividend. Buy half a position and watch, but don't buy heavily because it may
drop badly during a correction.
Since he recommended this, it’s gone from $22 to $46. This is medical technology for spying related injuries. The stock price has taken off because the company has gotten their act together and has started to move outside of the US. Their sales teams are in place. A lot of their competitors have not been allocating capital towards the spine business. This company just came out with a new robotic invention that will help surgeons do all the spine surgeries. Earnings have jumped up nicely, and he is expecting anywhere from $143-$178 a share over the next couple of years, but we are still seeing the stock trading at roughly 32X earnings. Wait for a pullback or just buy half for the moment.
David DriscollThis is a tiny little $2 billion company that is in robotics of spinal care. Growing at a wonderful rate, but the street hasn’t adapted to them.
David Driscoll- «
- ‹
- 1
- ›
- »
Popular Articles
Most Recent Experts
Globus Medical (GMED) Frequently Asked Questions
What is Globus Medical stock symbol?
Globus Medical is a American stock, trading under the symbol GMED (previously GMED-N on Stockchase) on the New York Stock Exchange (GMED). It is usually referred to as NYSE:GMED or GMED
Is Globus Medical a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on GMED (previously GMED-N on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Globus Medical.
Is Globus Medical a good investment or a top pick?
Globus Medical was recommended as a Top Pick by David Driscoll on 2016-06-07. Read the latest stock experts ratings for Globus Medical.
Why is Globus Medical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Globus Medical.
Is Globus Medical worth watching?
Globus Medical is followed by 10 investors on Stockchase and is a trending stock that is worth watching.
What is Globus Medical stock price?
On 2026-07-02, Globus Medical (GMED) stock closed at a price of $80.11.
The market hates medical devices now and there's little money made in bigger players like Medtronic.